NASDAQ
Merrimack Pharmaceuticals, Inc. (MACK) has a free cash flow growth of -345.42% as of Friday, May 29, 2026. This represents a 786.94% decrease compared to its 12-month average of -38.95%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.